In conclusion, plasma adiponectin was not affected by diabetes per se, suggesting that the often reported alterations in plasma adiponectins in Type 2 DM may be due to excess adipose tissue mass/ obesity. This evidence concerns the gene ADIPOQ and diabetes mellitus.